Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Atiprimod granted orphan drug status for multiple myeloma

Jan. 28, 2004

Zentaris and Solvay to advance LHRH antagonists through collaboration

Jan. 28, 2004

German approval for three-month Eligard

Jan. 28, 2004

Epigallocatechin-3 gallate inhibits VEGF-induced angiogenesis in vitro

Jan. 28, 2004

Inex and Enzon partner to develop Onco TCS

Jan. 27, 2004

Velcade recommended for approval in Europe

Jan. 27, 2004

EntreMed identifies peptide fragment of tissue factor pathway inhibitor

Jan. 27, 2004

European approval recommended for Lysodren

Jan. 27, 2004

CPMP recommends extension of Paxene indications

Jan. 27, 2004

CR-4: a novel tyrosine kinase inhibitor active against ALL and AML cell lines

Jan. 27, 2004

Popular Stories

Today's news in brief
BioWorld
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...